Patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey

Cobanoglu, Nazan; Ozcelik, Ugur; Çakır, Erkan; Eyuboglu, Tugba; Pekcan, Sevgi; Cinel, Guzin; Yalcin, Ebru; Kiper, Nural; Emiralioğlu, Nagehan; Şen, Velat; Şen, Hadice; Ercan, Omur; Cokugras, Haluk; Kilinc, Ayse; Al Shadfan, Lina; Yazan, Hakan; Altıntaş, Derya; Karagöz Işık, Dilek; Demir, Esen; Ozturk, Gokcen; Bingöl, Ayşen; Basaran, Abdurrahman; Sapan, Nihat; Çekiç, Şükrü; Çelebioğlu, Ebru; Aslan, Ayşe; Gursoy, Tugba; Tugcu, Gokcen; Ozdemir, Ali; Harmancı, Koray; Yildirim, Gonca; Köse, MEHMET; Hangül, MELİH; Tamay, Zeynep; Suleyman, Ayse; Yüksel, Hasan; Yılmaz, Özge; Ozcan, Gizem; Topal, Erdem; Can, Demet; Korkmaz Ekren, Pervin; Çaltepe, Gönül; Kılıç, Mehmet; Ozdogan, Sebnem; Doğru Ersöz, Deniz

doi:10.1002/ppul.24854

Patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey

Atıf İçin Kopyala

Cobanoglu N., Ozcelik U., Çakır E., Eyuboglu T. S., Pekcan S., Cinel G., ...Daha Fazla

PEDIATRIC PULMONOLOGY, cilt.55, sa.9, ss.2302-2306, 2020 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 55 Sayı: 9
Basım Tarihi: 2020
Doi Numarası: 10.1002/ppul.24854
Dergi Adı: PEDIATRIC PULMONOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
Sayfa Sayıları: ss.2302-2306
Anahtar Kelimeler: cystic fibrosis, modulator drugs, national registry, TEZACAFTOR-IVACAFTOR
Erciyes Üniversitesi Adresli: Evet

Özet

Background A better understanding of cystic fibrosis transmembrane conductance regulator biology has led to the development of modulator drugs such as ivacaftor, lumacaftor-ivacaftor, tezacaftor-ivacaftor, and elexacaftor-tezacaftor-ivacaftor. This cross-sectional study evaluated cystic fibrosis (CF) patients eligible for modulator drugs.